Document is current
Any future updates will be listed below
-
Authors
Bauer, Julia E. S.
Alibhai, Faisal J.
Vatani, Pouyan
Romero, David A.
Laflamme, Michael A.
Amon, Cristina H. https://orcid.org/0000-0003-4314-8120
-
Funding
Funding for this research was provided by:
Natural Sciences and Engineering Research Council of Canada
New Frontiers in Research Fund (NFRFT-2022-00447)
New Frontiers in Research Fund (NFRFT-2020-00787)
Canada Excellence Research Chairs, Government of Canada (CRC-2020-00245)
- License Information
-
More Information
Article History
Received: 12 October 2025
Accepted: 12 March 2026
First Online: 14 April 2026
Declarations
:
: Michael A. Laflamme is a scientific founder and consultant for Bluerock Therapeutics LP (Boston, MA, USA).
: All human pluripotent stem cell work was approved by the Stem Cell Oversight Committee of the Canadian Institutes of Health Research.
